Inhibrx Biosciences, Inc. (INBX)
(Delayed Data from NSDQ)
$20.98 USD
+0.05 (0.21%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $21.05 +0.07 (0.33%) 7:22 PM ET
3-Hold of 5 3
D Value F Growth C Momentum F VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
INBX 20.98 +0.05(0.21%)
Will INBX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INBX based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for INBX
Inhibrx Biosciences: Seeing Soon If The Momentum Is Just Hype
Noteworthy Tuesday Option Activity: INBX, ODP, AZO
Bullish Two Hundred Day Moving Average Cross - INBX
Inhibrx Biosciences Concludes 2025 Annual Stockholders Meeting
Analysts’ Opinions Are Mixed on These NA Stocks: Ibotta, Inc. Class A (IBTA) and Inhibrx Biosciences Inc (INBX)